Targeted therapies in AML: Evolving concepts for AML

被引：0
|
作者：
Serve, H. [1 ]
机构：
[1] Goethe Univ Frankfurt, Med Klin 2, Frankfurt, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [1] Shall We Dance: Evolving Partnerships of Targeted Therapies for AML
    Perl, Alexander E.
    Vyas, Paresh
    CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2719 - 2721
  • [2] Mechanisms of Resistance to Targeted Therapies in AML
    Jones, Matthew F.
    Smith, Catherine C.
    ANNUAL REVIEW OF CANCER BIOLOGY, 2024, 8 : 81 - 96
  • [3] Targeted Therapy in Pediatric AML: An Evolving Landscape
    LaQuita M. Jones
    Katherine Tarlock
    Todd Cooper
    Pediatric Drugs, 2021, 23 : 485 - 497
  • [4] Targeted Therapy in Pediatric AML: An Evolving Landscape
    Jones, LaQuita M.
    Tarlock, Katherine
    Cooper, Todd
    PEDIATRIC DRUGS, 2021, 23 (05) : 485 - 497
  • [5] Targeted Therapies for Pediatric AML: Gaps and Perspective
    Lonetti, Annalisa
    Pession, Andrea
    Masetti, Riccardo
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [6] The true impact of new targeted therapies for AML
    Rowe, Jacob M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (01) : 1 - 4
  • [7] Novel FLT3 Inhibitors and Targeted Therapies in AML
    Levis, M.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 35 - 37
  • [8] Novel FLT3 Inhibitors and Targeted Therapies in AML
    Levis, M.
    ANNALS OF HEMATOLOGY, 2015, 94 : S35 - S37
  • [9] Real world patient numbers for AML targeted therapies.
    dos Santos, Marcos Tadeu
    Smart, Dave
    Aita, Eloise
    Krein, Peter Mark
    Clark, Jordan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] The Time Has Come for Targeted Therapies for AML: Lights and Shadows
    Alessandro Fiorentini
    Debora Capelli
    Francesco Saraceni
    Diego Menotti
    Antonella Poloni
    Attilio Olivieri
    Oncology and Therapy, 2020, 8 : 13 - 32
12345